New Delhi, March 8 (IANS) A US-based subsidiary of Cipla has recalled more than 400 cartons of a generic anti-cancer medicine due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).In its latest enforcement report, the US health regulator said that Cipla USA, Inc, based in Warren, New Jersey, is recalling certain batches of Nilotinib Capsules in two strengths — 150 mg and 200 mg.The recall involves 271 cartons of one batch and 164 cartons of another batch of the …
Trending
- Mother Promise 2026 Movie Review: This Kannada Gangster Comedy Is Pure Absurd Fun
- Love Oh Love 2026 Movie Review: A Breezy, Feel-Good Romantic Entertainer That Flips the Script on Modern Love
- Lenin 2026 Movie Review: Akhil Akkineni’s Career-Best Rural Drama Draws Power From the Mahabharata
- Idhayam Murali Review: Atharvaa Shines In A Breezy But Overstretched Ode To Unspoken Love
- Ikka Movie Review: Sunny Deol and Akshaye Khanna Deliver a Gripping Courtroom Battle Rooted in Family and Conviction
- Dhamaal 4 Movie Review: Ajay Devgn, Riteish Deshmukh & Arshad Warsi Prove The Madness Never Gets Old!
- Harry Potter Bollywood Cast Goes Viral: Real or Fake? Full List Inside
- Trendy Tunics for Summer – Breezy Tunic Tops Styled for the Heat